Ocular Features and Associated Systemic Findings in SARS-CoV-2 Infection.
Ocul Immunol Inflamm
; 28(6): 916-921, 2020 Aug 17.
Artículo
en Inglés
| MEDLINE | ID: covidwho-737751
ABSTRACT
PURPOSES:
To describe the prevalence of ocular features among COVID-19 patients and their relationship with clinical data, inflammatory markers and respiratory support therapy (including CPAP); to investigate SARS-CoV-2 in ocular secretions of symptomatic patients.METHODS:
172 COVID-19 patients were evaluated for presence of ocular manifestations. Clinical and laboratory data were also reviewed. Conjunctival swabs were analyzed for SARS-CoV-2 by RT-PCR.RESULTS:
Forty-five patients (26.2%) reported ocular manifestations. Patients treated with CPAP were more likely to have ocular abnormalities (p <.01). The presence of ocular symptoms was not associated with more significant alterations on blood tests. Conjunctival swabs from patients with suspect conjunctivitis yielded negative results for SARS-CoV-2.CONCLUSIONS:
Ocular features are not infrequent in COVID-19 patients, but the presence of SARS-CoV-2 in ocular secretions is low. Ocular manifestations in hospitalized COVID-19 patients can also be a consequence of respiratory support therapy. Prevention of possible transmission through ocular secretions is still recommended.Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Neumonía Viral
/
ARN Viral
/
Conjuntivitis Viral
/
Infecciones por Coronavirus
/
Conjuntiva
/
Pandemias
/
Betacoronavirus
Tipo de estudio:
Estudios diagnósticos
/
Estudio experimental
/
Estudio observacional
/
Estudio pronóstico
/
Ensayo controlado aleatorizado
Tópicos:
Covid persistente
Límite:
Femenino
/
Humanos
/
Masculino
/
Middle aged
Idioma:
Inglés
Revista:
Ocul Immunol Inflamm
Asunto de la revista:
Alergia e Inmunología
/
Oftalmología
Año:
2020
Tipo del documento:
Artículo
País de afiliación:
09273948.2020.1781198
Similares
MEDLINE
...
LILACS
LIS